London Company of Virginia’s PetMed Express PETS Stock Holding History

London Company of Virginia’s Portfolio PETS Stock Details PETS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-4,760	Closed	-$210K	–	137
2018 Q2	$210K	Buy	+4,760	New	+$184K	﹤0.01%	135
2018 Q1	–	Sell	-4,760	Closed	-$217K	–	138
2017 Q4	$217K	Buy	+4,760	New	+$188K	﹤0.01%	131

Other funds holding PETS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

EIP

Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

PCM

Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

OCMI

Oaktop Capital Management II Chatham, New Jersey $2.35B AUM 214.39% 1-Year Est. Return

London Company of Virginia's PETS Position: Q3 2018 in Review

London Company of Virginia sold out of PetMed Express (PETS) in Q3 2018, closing a stake of 4,760 shares — an estimated $210K sold.

London Company of Virginia first reported a position in PETS in Q4 2017 and held it in 2 quarters. The position peaked at $217K in Q4 2017. 199 funds tracked by Wall St. Rank hold PETS as of Q3 2018.

London Company of Virginia reported no remaining PetMed Express position as of Q3 2018 after selling out during the quarter.
London Company of Virginia sold 4,760 PetMed Express shares in Q3 2018, an estimated $210K.
London Company of Virginia first reported a position in PetMed Express in Q4 2017 and held it in 2 quarters.
London Company of Virginia's PetMed Express position peaked at $217K in Q4 2017.
199 funds tracked by Wall St. Rank held PetMed Express as of Q3 2018.

Based on London Company of Virginia's 13F filing for Q3 2018, filed 14 Nov 2018.